According to a recent market study published by Growth Market Reports, titled, “Wound Irrigation Solution Market by Drug Type, by Type of Wound, by Application, by Distribution Channel, and by Region: Size, Share, Trends and Opportunity Analysis, 2015-2030”, the market was valued at US$ 1,468.8 Million in 2021 and is expected to expand at a growth rate of 3.2% by 2030.

Get Sample Report @ https://growthmarketreports.com/request-sample/5220

Wound irrigation is defined as the administration of a steady flow of a saline solution across an open wound before treating it. The process is done in order to achieve wound hydration, and to assist with the visual examination. Wound irrigation helps to remove deep debris and supports in cleaning wounds. Wound irrigation solution is formulated to sanitize injury and remove elements that affect the healing process. Examples of wound irrigation solutions include regular saline, sterile water, potable water, saline solution, and hydrogen peroxide. The solution is used in order to disinfect scratches, bruises, and other damage on the skin.

The wound irrigation solution market has been fragmented based on type, type of wound, application, and distribution channel. By type, the global wound irrigation solution market is categorized as wetting agents and antiseptics. In terms of type of wound, the market is categorized as burns, diabetic foot ulcer, pressure ulcer, venous ulcer, surgical wounds, and others. By application, the market is segmented as acute care hospitals, ambulatory surgical center, and wound care clinics & private offices. By distribution channel, the market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies. Considering regions, the market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.

The Coronavirus disease 2019 (COVID-19) pandemic highlighted economic disparities, global interdependence, and governance challenges. However, the COVID-19 outbreak has slightly negative impact on the wound irrigation solution, due to the lack of a defined line of supply chain during the pandemic. The pandemic disrupted various businesses and supply chains. The production chain for these therapeutic agents was somewhat reduced. Manufacturing units were operating at 50% capacity, owing to COVID-19 restrictions.

As per Growth Market Reports industry analyst, Ruchika Sharma, “The expanding healthcare and R&D activities are expected to contribute to the growth of the global wound irrigation solution market. Increasing investments from key market players for R&D activities and rising focus on product innovations are expected to trigger the demand for wound irrigation solution in the coming years. Demand for wound irrigation solution is projected to grow in the coming years, due to rising number of patients suffering from skin diseases such as diabetes, psoriasis, and eczema.”

A supply chain is a network between manufacturers and suppliers to produce and distribute a specific product to the final buyers. This network includes different people, regulatory bodies, entities, information, and resources. Entities in the supply chain include raw material suppliers, manufacturers, logistics, warehouses, pharmacies, finance, distributors, and customers. Supply chain management is an essential part of any business. If the supply chain of wound irrigation solution is hampered, the patients suffering from chronic ailments are not treated on time, resulting in the severe skin diseases.

Key Takeaways from the Study:

  • Players in the global wound irrigation solution market include Mölnlycke Health Care AB, Smith & Nephew, Convatec, Cardinal Health, B. Braun SE, BD, MCKESSON CORPORATION, Next Science, REGENO GmbH, Schülke & Mayr GmbH, SERAG-WIESSNER GmbH & Co. KG, Irrimax Corporation, Axio Biosolutions Pvt Ltd, Zimmer Biomet, ActiMaris AG held a major market share of the wound irrigation solution market in 2021.
  • Rising number of road accidents and patients suffering from skin diseases are contributing to the growth of the global wound irrigation solution market.
  • In terms of type, the global wound irrigation solution market is categorized as wetting agents and antiseptics. The antiseptics segment is projected to expand at a significant CAGR during the forecast period, owing its high usage in cleaning of skin and wounds to prevent the growth of bacteria.
  • Based on type of wound, the global wound irrigation solution market is categorized as burns, diabetic foot ulcer, pressure ulcer, venous ulcer, surgical wounds, and others. The pressure ulcer segment is projected to hold a significant share of the market during the forecast period, as it is an injury on the skin and underlying tissue. It is primarily caused due to prolonged pressure on the skin. Patients confined to bed rest or wheelchair for long periods of time suffer from pressure ulcers.
  • In terms of regions, the global wound irrigation solution market is divided into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. North America is projected to account for a significant share of the wound irrigation solution market during the forecast period, owing to the increasing facilities for treatment and well-established healthcare system in the region. Europe holds a large share of the market, due to high patient base in the region.

Report Scope:

Report Metric

Details

Market Value in 2021

US$ 1,468.8 Million

Market Growth Rate (from 2022 to 2030)

3.2 %

Historical Data

2015 & 2020

Base Year

2021

Forecast Period

2022 – 2030

Units Considered

Value (US$ Million)

Market Segments

By type, By type of wound, By Application, By distribution channel, and by region

Key Companies Profiled

Mölnlycke Health Care AB, Smith & Nephew, Convatec, Cardinal Health, B. Braun SE, BD, MCKESSON CORPORATION, Next Science, REGENO GmbH, Schülke & Mayr GmbH, SERAG-WIESSNER GmbH & Co. KG, Irrimax Corporation, Axio Biosolutions Pvt Ltd, Zimmer Biomet, ActiMaris AG

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet research requirements

Target Audience:

  • Supply-side: Manufacturers and distributors
  • Demand Side: Healthcare industry and pharmaceutical industry
  • Regulatory Side: Concerned government authorities and other approved regulatory bodies
  • Associations and Industry Bodies: Food and Drug Administration (FDA) and World Health Organization (WHO)